![]()
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
References
Additional References at PubMed
Genomics
miRNA Target Status
Predicted Targets
Summary Value | Count of predictions: | 41926 | Count of gene targets: | 15972 | Count of transcripts: | 35287 | Interacting mature miRNAs: | hsa-miR-920 | Prediction methods: | Microtar, Miranda, Pita, Rnahybrid, Targetscan | Result types: | miRGate_prediction | |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
Expression
RNA-SEQ Expression
High: > 1000 TPM value
Medium: Between 11 and 1000 TPMLow: Between 0.5 and 10 TPM Below Cutoff: < 0.5 TPM
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | adipose tissue | appendage | entire extraembryonic component | |
High | |||||||||||||||
Medium | 1 | 1 | |||||||||||||
Low | 14 | 18 | 34 | 22 | 36 | 22 | 46 | 4 | 25 | 17 | 38 | 33 | 5 | 17 | 1 |
Below cutoff | 6 | 7 | 4 | 1 | 1 | 10 | 4 | 6 | 2 | 3 | 3 | 1 | 5 |
Sequence
Nucleotide Sequences
Reference Sequences
RefSeq Acc Id: | ENST00000401373 | ||||||||
RefSeq Status: | |||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NR_030625 | ||||||||||||||||||||||||
RefSeq Status: | PROVISIONAL | ||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
Clinical Variants
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 12p12.3-12.1(chr12:19265334-25482589)x1 | copy number loss | See cases [RCV000135588] | Chr12:19265334..25482589 [GRCh38] Chr12:19418268..25635523 [GRCh37] Chr12:19309535..25526790 [NCBI36] Chr12:12p12.3-12.1 |
likely pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:121255-34603274)x3 | copy number gain | See cases [RCV000136611] | Chr12:121255..34603274 [GRCh38] Chr12:282465..34756209 [GRCh37] Chr12:100682..34647476 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:121271-34603261)x3 | copy number gain | See cases [RCV000139052] | Chr12:121271..34603261 [GRCh38] Chr12:282465..34756196 [GRCh37] Chr12:100698..34647463 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-q24.33(chr12:121271-133196807)x3 | copy number gain | See cases [RCV000139555] | Chr12:121271..133196807 [GRCh38] Chr12:282465..133773393 [GRCh37] Chr12:100698..132283466 [NCBI36] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:54427-34608071)x4 | copy number gain | See cases [RCV000139787] | Chr12:54427..34608071 [GRCh38] Chr12:282465..34761006 [GRCh37] Chr12:33854..34652273 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p12.1(chr12:23460257-24693739)x1 | copy number loss | See cases [RCV000141828] | Chr12:23460257..24693739 [GRCh38] Chr12:23613191..24846673 [GRCh37] Chr12:23504458..24737940 [NCBI36] Chr12:12p12.1 |
likely pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:64620-34682902)x4 | copy number gain | See cases [RCV000142149] | Chr12:64620..34682902 [GRCh38] Chr12:173786..34835837 [GRCh37] Chr12:44047..34727104 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-11.22(chr12:121055-28415184)x1 | copy number loss | See cases [RCV000052776] | Chr12:121055..28415184 [GRCh38] Chr12:282465..28568117 [GRCh37] Chr12:100482..28459384 [NCBI36] Chr12:12p13.33-11.22 |
pathogenic |
GRCh38/hg38 12p12.3-11.23(chr12:19295848-27012560)x1 | copy number loss | See cases [RCV000052782] | Chr12:19295848..27012560 [GRCh38] Chr12:19448782..27165493 [GRCh37] Chr12:19340049..27056760 [NCBI36] Chr12:12p12.3-11.23 |
pathogenic |
GRCh38/hg38 12p12.1-11.21(chr12:21771052-32222232)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052783]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052783]|See cases [RCV000052783] | Chr12:21771052..32222232 [GRCh38] Chr12:21923986..32375166 [GRCh37] Chr12:21815253..32266433 [NCBI36] Chr12:12p12.1-11.21 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:77187-34380176)x3 | copy number gain | See cases [RCV000053660] | Chr12:77187..34380176 [GRCh38] Chr12:282465..34533111 [GRCh37] Chr12:56614..34424378 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-12.1(chr12:80412-25470329)x3 | copy number gain | See cases [RCV000053662] | Chr12:80412..25470329 [GRCh38] Chr12:282465..25623263 [GRCh37] Chr12:59839..25514530 [NCBI36] Chr12:12p13.33-12.1 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:212976-33926913)x4 | copy number gain | See cases [RCV000053666] | Chr12:212976..33926913 [GRCh38] Chr12:322142..34079848 [GRCh37] Chr12:192403..33971115 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p12.3-12.1(chr12:18252085-25696258)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053670]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053670]|See cases [RCV000053670] | Chr12:18252085..25696258 [GRCh38] Chr12:18405019..25849192 [GRCh37] Chr12:18296286..25740459 [NCBI36] Chr12:12p12.3-12.1 |
pathogenic |
Additional Information
External Database Links
Database | Acc Id | Source(s) |
COSMIC | MIR920 | COSMIC |
Ensembl Genes | ENSG00000216192 | Ensembl, ENTREZGENE |
Ensembl Transcript | ENST00000401373 | ENTREZGENE |
GTEx | ENSG00000216192 | GTEx |
HGNC ID | HGNC:33670 | ENTREZGENE |
Human Proteome Map | MIR920 | Human Proteome Map |
miRBase | MI0005712 | ENTREZGENE |
NCBI Gene | 100126320 | ENTREZGENE |
PharmGKB | PA164722998 | PharmGKB |
RNAcentral | URS000067E0B9 | RNACentral |
URS000075EE93 | RNACentral |